215 related articles for article (PubMed ID: 28637198)
61. Search for new therapeutics against HIV-1 via dual inhibition of RNase H and integrase: current status and future challenges.
Kharkwal H; Kumar BK; Murugesan S; Singhvi G; Avasthi P; Goyal A; Jamalis J; Chander S
Future Med Chem; 2021 Feb; 13(3):269-286. PubMed ID: 33399497
[TBL] [Abstract][Full Text] [Related]
62. Effects of mutations in the polymerase domain on the polymerase, RNase H and strand transfer activities of human immunodeficiency virus type 1 reverse transcriptase.
Gao HQ; Boyer PL; Arnold E; Hughes SH
J Mol Biol; 1998 Apr; 277(3):559-72. PubMed ID: 9533880
[TBL] [Abstract][Full Text] [Related]
63. Coordination between the polymerase and RNase H activity of HIV-1 reverse transcriptase.
Figiel M; Krepl M; Poznanski J; Golab A; Šponer J; Nowotny M
Nucleic Acids Res; 2017 Apr; 45(6):3341-3352. PubMed ID: 28108662
[TBL] [Abstract][Full Text] [Related]
64. Activity of the isolated HIV RNase H domain and specific inhibition by N-hydroxyimides.
Hang JQ; Rajendran S; Yang Y; Li Y; In PW; Overton H; Parkes KE; Cammack N; Martin JA; Klumpp K
Biochem Biophys Res Commun; 2004 Apr; 317(2):321-9. PubMed ID: 15063760
[TBL] [Abstract][Full Text] [Related]
65. Inhibition of human immunodeficiency virus type 1 reverse transcriptase, RNase H, and integrase activities by hydroxytropolones.
Didierjean J; Isel C; Querré F; Mouscadet JF; Aubertin AM; Valnot JY; Piettre SR; Marquet R
Antimicrob Agents Chemother; 2005 Dec; 49(12):4884-94. PubMed ID: 16304149
[TBL] [Abstract][Full Text] [Related]
66. New anthraquinone derivatives as inhibitors of the HIV-1 reverse transcriptase-associated ribonuclease H function.
Esposito F; Corona A; Zinzula L; Kharlamova T; Tramontano E
Chemotherapy; 2012; 58(4):299-307. PubMed ID: 23128501
[TBL] [Abstract][Full Text] [Related]
67. Elicitor mediated enhancement of shoot biomass and lupeol production in
Pathak AR; Patel SR; Joshi AG; Shrivastava N; Sindhav G; Sharma S; Ansari H
Nat Prod Res; 2023 Jun; 37(11):1767-1773. PubMed ID: 36059233
[No Abstract] [Full Text] [Related]
68. Structural modulation study of inhibitory compounds for ribonuclease H activity of human immunodeficiency virus type 1 reverse transcriptase.
Yanagita H; Fudo S; Urano E; Ichikawa R; Ogata M; Yokota M; Murakami T; Wu H; Chiba J; Komano J; Hoshino T
Chem Pharm Bull (Tokyo); 2012; 60(6):764-71. PubMed ID: 22689429
[TBL] [Abstract][Full Text] [Related]
69. 5-Hydroxypyrido[2,3-b]pyrazin-6(5H)-one derivatives as novel dual inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H and integrase.
Sun L; Gao P; Dong G; Zhang X; Cheng X; Ding X; Wang X; Daelemans D; De Clercq E; Pannecouque C; Menéndez-Arias L; Zhan P; Liu X
Eur J Med Chem; 2018 Jul; 155():714-724. PubMed ID: 29940462
[TBL] [Abstract][Full Text] [Related]
70. Inhibitory Effect of 2,3,5,6-Tetrafluoro-4-[4-(aryl)-1H-1,2,3-triazol-1-yl]benzenesulfonamide Derivatives on HIV Reverse Transcriptase Associated RNase H Activities.
Pala N; Esposito F; Rogolino D; Carcelli M; Sanna V; Palomba M; Naesens L; Corona A; Grandi N; Tramontano E; Sechi M
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27556447
[TBL] [Abstract][Full Text] [Related]
71. Dual HIV-1 reverse transcriptase and integrase inhibitors from
Sanna C; Rigano D; Corona A; Piano D; Formisano C; Farci D; Franzini G; Ballero M; Chianese G; Tramontano E; Taglialatela-Scafati O; Esposito F
Nat Prod Res; 2019 Jun; 33(12):1798-1803. PubMed ID: 29397771
[TBL] [Abstract][Full Text] [Related]
72. Mutations in human immunodeficiency virus type 1 RNase H primer grip enhance 3'-azido-3'-deoxythymidine resistance.
Delviks-Frankenberry KA; Nikolenko GN; Barr R; Pathak VK
J Virol; 2007 Jul; 81(13):6837-45. PubMed ID: 17428874
[TBL] [Abstract][Full Text] [Related]
73. Interaction of HIV-1 reverse transcriptase ribonuclease H with an acylhydrazone inhibitor.
Gong Q; Menon L; Ilina T; Miller LG; Ahn J; Parniak MA; Ishima R
Chem Biol Drug Des; 2011 Jan; 77(1):39-47. PubMed ID: 21114787
[TBL] [Abstract][Full Text] [Related]
74. Indian sarsaparilla, Hemidesmus indicus (L.) R. Br. ex Schult: tissue culture studies.
Kher MM; Shekhawat MS; Nataraj M; Teixeira da Silva JA
Appl Microbiol Biotechnol; 2020 Aug; 104(15):6463-6479. PubMed ID: 32535696
[TBL] [Abstract][Full Text] [Related]
75. Structural basis for the inhibition of RNase H activity of HIV-1 reverse transcriptase by RNase H active site-directed inhibitors.
Su HP; Yan Y; Prasad GS; Smith RF; Daniels CL; Abeywickrema PD; Reid JC; Loughran HM; Kornienko M; Sharma S; Grobler JA; Xu B; Sardana V; Allison TJ; Williams PD; Darke PL; Hazuda DJ; Munshi S
J Virol; 2010 Aug; 84(15):7625-33. PubMed ID: 20484498
[TBL] [Abstract][Full Text] [Related]
76. Structure-based design of non-nucleoside reverse transcriptase inhibitors of drug-resistant human immunodeficiency virus.
Mao C; Sudbeck EA; Venkatachalam TK; Uckun FM
Antivir Chem Chemother; 1999 Sep; 10(5):233-40. PubMed ID: 10574178
[TBL] [Abstract][Full Text] [Related]
77. An evaluation of the RNase H inhibitory effects of Vietnamese medicinal plant extracts and natural compounds.
Tai BH; Nhut ND; Nhiem NX; Quang TH; Thanh Ngan NT; Thuy Luyen BT; Huong TT; Wilson J; Beutler JA; Ban NK; Cuong NM; Kim YH
Pharm Biol; 2011 Oct; 49(10):1046-51. PubMed ID: 21595586
[TBL] [Abstract][Full Text] [Related]
78. Inhibitor binding alters the directions of domain motions in HIV-1 reverse transcriptase.
Temiz NA; Bahar I
Proteins; 2002 Oct; 49(1):61-70. PubMed ID: 12211016
[TBL] [Abstract][Full Text] [Related]
79. Ribonuclease H, an unexploited target for antiviral intervention against HIV and hepatitis B virus.
Tramontano E; Corona A; Menéndez-Arias L
Antiviral Res; 2019 Nov; 171():104613. PubMed ID: 31550450
[TBL] [Abstract][Full Text] [Related]
80. Virtual screening models for prediction of HIV-1 RT associated RNase H inhibition.
Poongavanam V; Kongsted J
PLoS One; 2013; 8(9):e73478. PubMed ID: 24066050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
